ADVISORY-Alerts incorrectly sourced to Arcturus Therapeutics withdrawn

Reuters

08/29

ADVISORY-Alerts incorrectly sourced to Arcturus <a href="https://laohu8.com/S/LENZ">Therapeutics</a> withdrawn

Alerts incorrectly attributed to Arcturus Therapeutics ARCT.O about Meiji Seika Pharma getting approval for the KOSTAIVE MRNA vaccine in Japan have been withdrawn. Meiji has an ongoing agreement for distribution and sales in Japan of Arcturus' KOSTAIVE, a vaccine candidate against COVID-19.

There will be no substitute.

STORY_NUMBER:nFWN3UK22T

STORY_DATE:29/08/2025

STORY_TIME:[10:11:05 AM GMT]

((bangalore.newsroom@thomsonreuters.com))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2563337044"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2563337044\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2563337044?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 18:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2563337044","market":"us","top_or_hot":-1,"title":"ADVISORY-Alerts incorrectly sourced to Arcturus Therapeutics withdrawn","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>ADVISORY-Alerts incorrectly sourced to Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> withdrawn</title></head><body><p>Alerts incorrectly attributed to Arcturus Therapeutics <span>ARCT.O</span> about Meiji Seika Pharma getting approval for the KOSTAIVE MRNA vaccine in Japan have been withdrawn. Meiji has an ongoing agreement for distribution and sales in Japan of Arcturus' KOSTAIVE, a vaccine candidate against COVID-19.</p><p>There will be no substitute. </p><p>STORY_NUMBER:<span>nFWN3UK22T</span></p><p>STORY_DATE:<span>29/08/2025</span></p><p>STORY_TIME:[10:11:05 AM GMT]</p><p> ((bangalore.newsroom@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADVISORY-Alerts incorrectly sourced to Arcturus Therapeutics withdrawn</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADVISORY-Alerts incorrectly sourced to Arcturus Therapeutics withdrawn\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-29 18:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>ADVISORY-Alerts incorrectly sourced to Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> withdrawn</title></head><body><p>Alerts incorrectly attributed to Arcturus Therapeutics <span>ARCT.O</span> about Meiji Seika Pharma getting approval for the KOSTAIVE MRNA vaccine in Japan have been withdrawn. Meiji has an ongoing agreement for distribution and sales in Japan of Arcturus' KOSTAIVE, a vaccine candidate against COVID-19.</p><p>There will be no substitute. </p><p>STORY_NUMBER:<span>nFWN3UK22T</span></p><p>STORY_DATE:<span>29/08/2025</span></p><p>STORY_TIME:[10:11:05 AM GMT]</p><p> ((bangalore.newsroom@thomsonreuters.com))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARCT","symbol_name":"Arcturus Therapeutics Ltd.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UK22T:1","article_id":"2563337044","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2563337044","pubTimestamp":1756464597,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"ADVISORY-Alerts incorrectly sourced to Arcturus Therapeutics withdrawnAlerts incorrectly attributed to Arcturus Therapeutics ARCT.O about Meiji Seika Pharma getting approval for the KOSTAIVE MRNA vacc","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARCT":"Arcturus Therapeutics Ltd.","BK4139":"生物科技"},"translate_title":"咨询-撤回错误来源为Arcturus Therapeutics的警报","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARCT":0.9},"content_text":"ADVISORY-Alerts incorrectly sourced to Arcturus Therapeutics withdrawnAlerts incorrectly attributed to Arcturus Therapeutics ARCT.O about Meiji Seika Pharma getting approval for the KOSTAIVE MRNA vaccine in Japan have been withdrawn. Meiji has an ongoing agreement for distribution and sales in Japan of Arcturus' KOSTAIVE, a vaccine candidate against COVID-19.There will be no substitute. STORY_NUMBER:nFWN3UK22TSTORY_DATE:29/08/2025STORY_TIME:[10:11:05 AM GMT] ((bangalore.newsroom@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}